Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
Last trade$10.20
Day change+$0.105 (+1.04%)
Day range$10.09 – $10.37
Volume79,854
Market cap$892M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for AFYA.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for AFYA.
Recent news
Company coverage with links to the original publishers.
Afya reported quarterly earnings of $0.4 per share, missing the consensus estimate of $1.07 per share by 62.62%, though revenues exceeded expectations. The company received a Zacks Rank #5 (Strong Sell) rating due to unfavorable estimate revisions, and shares have underperformed the market by 30.4% year-to-date. The Schools industry ranks in the bottom 28% of Zacks industries.
Afya is expected to report Q3 2026 earnings of $1.07 per share with 9.9% revenue growth, but faces headwinds with a Zacks Rank #5 and 0% Earnings ESP, making an earnings beat unlikely. In contrast, American Public Education is positioned as a more compelling earnings-beat candidate with a Zacks Rank #2 and +1.56% Earnings ESP, supported by a history of beating consensus estimates.
A comparison of two education stocks shows Afya (AFYA) presents a better value opportunity than Universal Technical Institute (UTI). Afya has a stronger Zacks Rank of #2 (Buy) versus UTI's #3 (Hold), and significantly better valuation metrics including a forward P/E of 7.54 compared to UTI's 26.85, earning Afya an A Value grade versus UTI's C grade.
Zacks identifies Afya (AFYA) as an attractive value investment opportunity, citing its Zacks Rank #2 (Buy) rating and 'A' grade for Value. The stock trades at a P/E ratio of 8.67, below its industry average of 10.74, with favorable PEG, P/B, and P/CF ratios suggesting undervaluation relative to its earnings growth prospects.
The article discusses 5 top small-cap stocks that are Zacks Rank #1 (Strong Buy) or #2 (Buy) stocks, including Soundhound AI, Afya, Castle Biosciences, TriMas, and Immersion. The article provides an overview of each company's business, market cap, stock performance, and earnings growth outlook.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Mar 25, 2026
$0.6565
Apr 6, 2026
recurring
Mar 26, 2025
$0.232
Apr 4, 2025
unknown
Stock splits
Historical share-structure events and their execution dates.